Protective Effect and Mechanism of Huanglian Jiedu Tang on Diabetic Nephropathy Rats

Yi-ping WANG,Li-yan ZHANG,Yi-zhong WANG,Xiao-lan CUI,Shan-shan GUO

DOI: https://doi.org/10.13241/j.cnki.pmb.2018.05.012

2018-01-01

Abstract:Objective:To explore the protective effect and possible mechanisms of Huanglian Jiedu Tang (HLJDT) on Streptozocin (STZ)-induced diabetic nephropathy (DN) rats.Methods:Male Wistar rats were randomly divided into the control group (n=10) and the model group received intraperitoneal injection of STZ (55 mg/kg).All successful model rats with blood glucose ≥ 16.7 mmol/L and urine glucose ≥ 4+ were then divided into the model group (n=12),the low dose one,the middle dose one and the High dose one (each n=12).Water was orally given to the rats in the control group and the model group,and HLJDT (60,120 and 240 g· kg-1· d-1) were orally given into the other three groups respectively for 12 weeks.12 weeks later,all the rats were sacrificed and the biochemical indicators such as the fasting blood glucose (FBG),triglyceride (TG),blood urea nitrogen (BUN),serum creatinine (Scr),urine protein 24 h (UP 24 h),nitric oxide (NO),malondialdehyde (MDA) and superoxide dismutase (SOD) were measured.TGF-β1,p38MAPK and Caspase-3 gene and protein expression in kidney were detected by RT-qPCR and western blot.Results:Compared with model group,the body weight (BW) increased,the kidney weight (KW),KW/BW ratio and FBG were significantly decreased in HLJDT-Middle and HLJDT-High groups.BG,BUN,Scr and UP 24 h were significantly increased in model group compared with the control group,but decreased markly in HLJDT-High group compared with model group.And HLJDT-Middle and HLJDT-High groups also decreased biochemical parameters:MDA,and increased NO and SOD compared with the model group.Moreover,the mRNA and protein expression ofTGF-β1,p38MAPK and Caspase-3 in model group were significantly higher than the control group and were significantly lower than the model group after HLJDT treatment (all P＜0.05,P＜0.01).Conclusion:Our research provides experimental evidence that HLJDT protects kidneys in DN through blood glucose control,reducing oxidative stress and down-regulating expressions of TGF-β1,p38MAPK and Caspase-3.